BARRECA, Maria Letizia
 Distribuzione geografica
Continente #
NA - Nord America 1.904
EU - Europa 1.387
AS - Asia 396
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 3.696
Nazione #
US - Stati Uniti d'America 1.885
IE - Irlanda 373
SE - Svezia 323
UA - Ucraina 280
CN - Cina 253
DE - Germania 145
VN - Vietnam 116
GB - Regno Unito 98
FI - Finlandia 77
IT - Italia 23
RU - Federazione Russa 23
CA - Canada 18
IN - India 15
BE - Belgio 12
FR - Francia 6
IR - Iran 6
PL - Polonia 6
AT - Austria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 2
EG - Egitto 2
NL - Olanda 2
NZ - Nuova Zelanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.696
Città #
Jacksonville 487
Dublin 373
Chandler 364
Nyköping 224
Ashburn 127
Dong Ket 115
Beijing 114
Princeton 75
Cambridge 73
Medford 71
Des Moines 58
Boardman 49
Dearborn 41
Lancaster 28
Ann Arbor 27
Woodbridge 27
Wilmington 19
Nanjing 18
Haikou 15
Jinan 15
Brussels 12
Hebei 12
Ottawa 12
Shenyang 11
Taizhou 11
Washington 11
Saint Petersburg 10
Pune 9
San Mateo 9
Seattle 9
Zhengzhou 8
Hangzhou 7
Norwalk 7
Auburn Hills 6
Leawood 6
Tianjin 6
Warsaw 6
Ardabil 5
Riva 5
Taiyuan 5
Fuzhou 4
London 4
Monmouth Junction 4
Nanchang 4
Ningbo 4
West Jordan 4
Augusta 3
Brooklyn 3
Cormeilles-en-Parisis 3
Edinburgh 3
Los Angeles 3
Mcallen 3
Milan 3
Montréal 3
New York 3
Sofia 3
Toronto 3
Vienna 3
Auckland 2
Bangalore 2
Cairo 2
Como 2
Dallas 2
Eden Prairie 2
Ferrara 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Houston 2
Kemerovo 2
Lanzhou 2
Lappeenranta 2
Manchester 2
Munich 2
Nanning 2
Novokuznetsk 2
Pagani 2
Perugia 2
Albuquerque 1
Amsterdam 1
Atlanta 1
Boston 1
Bratislava 1
Bucharest 1
Budapest 1
Cagliari 1
Changsha 1
Clearwater 1
Copenhagen 1
Corleone 1
Cupertino 1
Dubai 1
Evanston 1
Frigento 1
Geneva 1
Hanoi 1
Istanbul 1
Jiaxing 1
Keflavik 1
Kyiv 1
Totale 2.609
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 190
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 149
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 68
Anti-HIV agents: design and discovery of new potent RT inhibitors 65
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 64
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 62
Binding modes of noncompetitive AMPA antagonists: a computational approach 62
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 61
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 60
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 59
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 58
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 58
Computational studies of inhibitor resistance in HIV-1 integrase 58
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 56
Efficient 3D Database screening for novel HIV-1 IN inhibitors 56
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 56
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 55
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 53
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 53
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 53
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 53
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 52
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 52
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 52
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 52
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 51
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 51
Pharmacophore-based design of HIV-1 integrase inhibitors 50
Dynamic pharmacophore model development and testing 50
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 50
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 50
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 50
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 49
Design and synthesis of new HIV-1 NNRTIs 49
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 49
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 49
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 49
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 48
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 48
Design and Synthesis of NR2B Subtype-Selective Antagonist 47
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 46
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 44
New trends in the development of AMPA receptor antagonists 43
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 42
Synthesis of new potential HIV-1 integrase inhibitors 42
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 42
Molecular dynamics studies of the HIV-1 integrase 41
Molecular dynamics studies of the full-length integrase-DNA complex 40
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 40
Discovery of novel HIV-1 integrase inhibitors through computational strategies 40
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 40
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 40
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 40
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 40
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 40
Rational design and synthesis of novel NNRTI TBZ analogues 40
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 40
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 40
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 38
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 37
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 37
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 36
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 35
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 34
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 34
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 34
null 28
null 27
null 27
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 27
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 26
null 25
null 25
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 24
null 24
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 23
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 16
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 16
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 15
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 11
Totale 3.736
Categoria #
all - tutte 12.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020683 158 69 0 67 2 41 80 71 10 75 107 3
2020/2021597 74 0 105 15 7 68 1 69 1 79 48 130
2021/2022457 5 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024281 25 51 17 46 34 68 8 26 1 5 0 0
Totale 3.736